SCOPUS 정보 검색 플랫폼

Archives of Internal Medicine

Volumn 162, Issue 22, 2002, Pages 2637-

Lack of cardioprotective effect of naproxen [13]

(3) Mukherjee, Debabrata a Nissen, Steven E a Topol, Eric J a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN RECEPTOR; ROFECOXIB;

CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; HEART INFARCTION; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; NAPROXEN; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0037049351 PISSN: 00039926 EISSN: None Source Type: Journal
DOI: 10.1001/archinte.162.22.2637 Document Type: Letter

Times cited : (9)

References (11)

1
- 0037182025
- Selective COX-2 inhibitors, NSAIDs, aspirin, and myocardial infarction
- Dalen JE. Selective COX-2 inhibitors, NSAIDs, aspirin, and myocardial infarction [editorial]. Arch Intern Med 2002;162:1091-1092.
- (2002) Arch Intern Med , vol.162 , pp. 1091-1092
- Dalen, J.E.¹

2
- 0037182013
- Nonsteroidal anti-inflammatory drug use and acute myocardial infarction
- Solomon DH, Glynn RJ, Levin R, Avorn J. Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med. 2002;162:1099-1104.
- (2002) Arch Intern Med , vol.162 , pp. 1099-1104
- Solomon, D.H.¹ Glynn, R.J.² Levin, R.³ Avorn, J.⁴

3
- 0037182008
- Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis
- Watson DJ, Rhodes T, Cai B, Guess HA. Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med. 2002;162:1105-1110.
- (2002) Arch Intern Med , vol.162 , pp. 1105-1110
- Watson, D.J.¹ Rhodes, T.² Cai, B.³ Guess, H.A.⁴

4
- 0037182023
- Association between naproxen use and protection against acute myocardial infarction
- Rahme E, Pilote L, LeLorier J. Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med. 2002;162:1111-1115.
- (2002) Arch Intern Med , vol.162 , pp. 1111-1115
- Rahme, E.¹ Pilote, L.² LeLorier, J.³

5
- 0035934070
- Risk of cardiovascular events associated with selective COX-2 inhibitors
- Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954-959.
- (2001) JAMA , vol.286 , pp. 954-959
- Mukherjee, D.¹ Nissen, S.E.² Topol, E.J.³

6
- 0003531985
- New York, NY: Oxford University Press
- Kelsey J, Whittemore A, Evans A, Thompson W. Methods in Observational Epidemiology. 2nd Ed. New York, NY: Oxford University Press; 1996.
- (1996) Methods in Observational Epidemiology. 2nd Ed.
- Kelsey, J.¹ Whittemore, A.² Evans, A.³ Thompson, W.⁴

7
- 0028304778
- Limitations in the application of case-control methodology
- Austin H, Hill HA, Flanders WD, Greenberg RS. Limitations in the application of case-control methodology. Epidemiol Rev. 1994;16:65-76.
- (1994) Epidemiol Rev , vol.16 , pp. 65-76
- Austin, H.¹ Hill, H.A.² Flanders, W.D.³ Greenberg, R.S.⁴

8
- 0018736142
- Bias in analytic research
- Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32:51-63.
- (1979) J Chronic Dis , vol.32 , pp. 51-63
- Sackett, D.L.¹

9
- 0037065519
- Non-steroidal antiinflammatory drugs and risk of serious coronary heart disease: An observational cohort study
- Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR. Non-steroidal antiinflammatory drugs and risk of serious coronary heart disease: An observational cohort study. Lancet. 2002;359:118-123.
- (2002) Lancet , vol.359 , pp. 118-123
- Ray, W.A.¹ Stein, C.M.² Hall, K.³ Daugherty, J.R.⁴ Griffin, M.R.⁵

10
- 0035859802
- Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries
- Hennan JK, Huang J, Barrett TD, et al. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation. 2001;104:820-825.
- (2001) Circulation , vol.104 , pp. 820-825
- Hennan, J.K.¹ Huang, J.² Barrett, T.D.³

11
- 0037134011
- Role of prostacyclin in the cardiovascular response to thromboxane A2
- Cheng Y, Austin SC, Rocca B, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002;296:539-541.
- (2002) Science , vol.296 , pp. 539-541
- Cheng, Y.¹ Austin, S.C.² Rocca, B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.